Pikkelysömör: vizsgálatok itt: Belgium

In Belgium 13 Also abroad 274

13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

4. fázisTaking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Brugge, Genk, Gent, Liège, Mons
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Gent, Jette, Leuven
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
3. fázisTaking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Bruxelles, Gent
Életkor
40 év and over
People
3040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
3. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Gent, Liège, Sint-Lambrechts-Woluwe
Életkor
12 év to 17 év
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
2/3. fázisNot yet taking people in Belgium
Prospective diagnostic performance of PET/CT using the novel fibroblast imaging tracer [18F]-AlF-FAPI-74 versus power doppler ultrasound in psoriasis patients with arthralgia: early detection of psoriatic arthritis
Where
Edegem, Leuven
Életkor
18 év and over
People
270
Run by
UZ Leuven
See details and how to join2026-526942-29-00 · EU 2026-526942-29-00
3. fázisTaking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Anderlecht, Brussels, Genk, Gent, Liège
Életkor
18 év and over
People
1088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
3. fázisTaking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Anderlecht, Brussels, Genk, Gent, Liège
Életkor
18 év and over
People
1182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
4. fázisTaking people
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Where
Leuven, Ghent University Hospital
Életkor
18 év and over
People
100 worldwide
Run by
CARE ARTHRITIS LTD.
See details and how to joinNCT06454188 · EU 2023-510242-24-00
No phaseTaking people
Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
Where
Brussels
Életkor
18 év and over
People
600
Run by
Jonathan Krygier
See details and how to joinNCT07234838
4. fázisTaking people
Proactive TDM Versus Standard Use of Biologics in Psoriasis
Where
Anderlecht, Brugge, Brussels, Eeklo, Geel, Gent, Gerpinnes, Jette, Kortrijk, Leuven, Liège, Maldegem, Sint-Lambrechts-Woluwe
Életkor
18 év and over
People
210
Run by
University Hospital, Ghent
See details and how to joinNCT06398106 · EU 2023-509637-39-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Aalst, Anderlecht, Charleroi, Genk, Leuven, Liège
Életkor
18 év to 75 év
People
1200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693
No phaseTaking people
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Where
Brussels
Életkor
2 év to 50 év
People
1000
Run by
Université Catholique de Louvain
See details and how to joinNCT07000916
No phaseTaking people
ProspectIve Cohort psoriASiS fOllow-up (PICASSO)
Where
Leuven
Életkor
12 év to 70 év
People
200
Run by
Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT05122039